Metraipolis › archive › dc_445ea9d8537b
Characterizing clinical toxicity in cancer combination therapies — Europe PMC PMID:41537239
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41537239
- DOI
- 10.1093/bioinformatics/btag007
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T11:30:05.847Z
- SHA-256 of the archived text
f65084528ad025504f0bae25ee7bc9d781560b353a9e1b30dbedb2bb96e11b41- Stable URL of this page
https://metraipolis.com/documento/dc_445ea9d8537b
How to cite
Characterizing clinical toxicity in cancer combination therapies — Europe PMC PMID:41537239 — Europe PMC (en), https://europepmc.org/article/MED/41537239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_445ea9d8537b (Metraipolis archive dc_445ea9d8537b, sha256 f65084528ad025504f0bae25ee7bc9d781560b353a9e1b30dbedb2bb96e11b41)
BibTeX
@misc{dc445ea9d8537b,
title = {Characterizing clinical toxicity in cancer combination therapies — Europe PMC PMID:41537239},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41537239},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_445ea9d8537b; sha256 f65084528ad025504f0bae25ee7bc9d781560b353a9e1b30dbedb2bb96e11b41},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41537239. Agents can read the archived copy with the MCP tool read_document.